Suchergebnisse - "Gottfried, Maya"

PubPharm (114)

1

Alectinib in Resected ALK-Positive Non-Small-Cell Lung Cancer

enthalten in: The New England journal of medicine | 2024

von Wu, Y. | Dziadziuszko, R. | Ahn, J. | +120

2

Blood tumor mutational burden and response to pembrolizumab plus chemotherapy in non-small cell lung cancer : KEYNOTE-782

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2024

von Bar, J. | Esteban, E. | Rodríguez-Abreu, D. | +20

3

Plasma Proteome-Based Test for First-Line Treatment Selection in Metastatic Non-Small Cell Lung Cancer

enthalten in: JCO precision oncology | 2024

von Christopoulos, P. | Harel, M. | McGregor, K. | +34

4

Biological insights from plasma proteomics of non-small cell lung cancer patients treated with immunotherapy

enthalten in: Frontiers in immunology | 2024

von Bar, J. | Leibowitz, R. | Reinmuth, N. | +24

5

Biological insights from plasma proteomics of non-small cell lung cancer patients treated with immunotherapy

enthalten in: bioRxiv.org | 2024

von Bar, J. | Leibowitz, R. | Reinmuth, N. | +24

6

Patient-Reported Health-Related Quality of Life in KEYNOTE-604 : Pembrolizumab or Placebo Added to Etoposide and Platinum as First-Line Therapy for Extensive-Stage SCLC

enthalten in: JTO clinical and research reports | 2023

von Kim, H. | Awad, M. | Navarro, A. | +17

7

Anti-angiogenic agents for NSCLC following first-line immunotherapy : Rationale, recent updates, and future perspectives

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2023

von Reck, M. | Popat, S. | Grohé, C. | +7

8

A novel decision-making tool for first-line treatment selection in metastatic non-small cell lung cancer based on plasma proteome profiling

enthalten in: bioRxiv.org | 2023

von Christopoulos, P. | Harel, M. | Lahav, C. | +21

9

Health-related quality of life in patients treated with pembrolizumab for microsatellite instability-high/mismatch repair-deficient advanced solid tumours : Results from the KEYNOTE-158 study

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Maio, M. | Amonkar, M. | Norquist, J. | +15

10

Tepotinib Efficacy and Safety in Patients with MET Exon 14 Skipping NSCLC : Outcomes in Patient Subgroups from the VISION Study with Relevance for Clinical Practice

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Le, X. | Sakai, H. | Felip, E. | +27

CommentIn: Clin Cancer Res. 2022 Mar 15;28(6):1055-1057. - PMID 34983790

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[12]